Everyone's a winner if we test less: the CODA action plan
Aust Health Rev. 2022 Jul 1. doi: 10.1071/AH22145. Online ahead of print.ABSTRACTIn this era of 'Choosing Wisely,' we present a four-step action plan to reduce unnecessary pathology testing and the associated patient harm (blood loss through repeated phlebotomy), economic cost and environmental impact. The authors are experts from the CODA group; a medical education and health-promotion charity that aims to build on the Choosing Wisely initiative to provide meaningful and sustainable actions to reduce the carbon footprint of healthcare, globally. Pathology testing is expensive and carbon-intensive, with as many as half of ...
Source: Australian Health Review - June 30, 2022 Category: Hospital Management Authors: Oliver Walsh Roger Harris Oliver Flower Matthew Anstey Forbes McGain Source Type: research

Establishing a community infusion service in Canterbury, New Zealand: strategies and lessons
J Prim Health Care. 2022 Jun;14(2):151-155. doi: 10.1071/HC21103.ABSTRACTBackground and context An increasing number of drugs and blood products need to be delivered by intravenous infusion. In the Canterbury region of New Zealand, these have historically been delivered at a hospital site; however, some infusions could be delivered in a community setting without compromising patient safety. Assessment of problem The Canterbury health system has a key strategic objective of delivering care close to patients' homes. In 2018, Canterbury district health board (DHB) put out a tender for a community infusion service that would d...
Source: Journal of Primary Health Care - June 30, 2022 Category: Primary Care Authors: Lisa McGonigle Brett Shand Graham McGeoch Source Type: research

Everyone's a winner if we test less: the CODA action plan
Aust Health Rev. 2022 Jul 1. doi: 10.1071/AH22145. Online ahead of print.ABSTRACTIn this era of 'Choosing Wisely,' we present a four-step action plan to reduce unnecessary pathology testing and the associated patient harm (blood loss through repeated phlebotomy), economic cost and environmental impact. The authors are experts from the CODA group; a medical education and health-promotion charity that aims to build on the Choosing Wisely initiative to provide meaningful and sustainable actions to reduce the carbon footprint of healthcare, globally. Pathology testing is expensive and carbon-intensive, with as many as half of ...
Source: Australian Health Review - June 30, 2022 Category: Hospital Management Authors: Oliver Walsh Roger Harris Oliver Flower Matthew Anstey Forbes McGain Source Type: research

Establishing a community infusion service in Canterbury, New Zealand: strategies and lessons
J Prim Health Care. 2022 Jun;14(2):151-155. doi: 10.1071/HC21103.ABSTRACTBackground and context An increasing number of drugs and blood products need to be delivered by intravenous infusion. In the Canterbury region of New Zealand, these have historically been delivered at a hospital site; however, some infusions could be delivered in a community setting without compromising patient safety. Assessment of problem The Canterbury health system has a key strategic objective of delivering care close to patients' homes. In 2018, Canterbury district health board (DHB) put out a tender for a community infusion service that would d...
Source: Journal of Primary Health Care - June 30, 2022 Category: Primary Care Authors: Lisa McGonigle Brett Shand Graham McGeoch Source Type: research

Everyone's a winner if we test less: the CODA action plan
Aust Health Rev. 2022 Jul 1. doi: 10.1071/AH22145. Online ahead of print.ABSTRACTIn this era of 'Choosing Wisely,' we present a four-step action plan to reduce unnecessary pathology testing and the associated patient harm (blood loss through repeated phlebotomy), economic cost and environmental impact. The authors are experts from the CODA group; a medical education and health-promotion charity that aims to build on the Choosing Wisely initiative to provide meaningful and sustainable actions to reduce the carbon footprint of healthcare, globally. Pathology testing is expensive and carbon-intensive, with as many as half of ...
Source: Australian Health Review - June 30, 2022 Category: Hospital Management Authors: Oliver Walsh Roger Harris Oliver Flower Matthew Anstey Forbes McGain Source Type: research

Establishing a community infusion service in Canterbury, New Zealand: strategies and lessons
J Prim Health Care. 2022 Jun;14(2):151-155. doi: 10.1071/HC21103.ABSTRACTBackground and context An increasing number of drugs and blood products need to be delivered by intravenous infusion. In the Canterbury region of New Zealand, these have historically been delivered at a hospital site; however, some infusions could be delivered in a community setting without compromising patient safety. Assessment of problem The Canterbury health system has a key strategic objective of delivering care close to patients' homes. In 2018, Canterbury district health board (DHB) put out a tender for a community infusion service that would d...
Source: Journal of Primary Health Care - June 30, 2022 Category: Primary Care Authors: Lisa McGonigle Brett Shand Graham McGeoch Source Type: research